Compare BCAB & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCAB | STRW |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | 41 | 9 |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 176.3M |
| IPO Year | 2020 | 2019 |
| Metric | BCAB | STRW |
|---|---|---|
| Price | $4.21 | $12.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $13.88 |
| AVG Volume (30 Days) | ★ 95.5K | 15.6K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 5.17% |
| EPS Growth | ★ 29.86 | 5.26 |
| EPS | N/A | ★ 0.60 |
| Revenue | $300,000.00 | ★ $154,999,000.00 |
| Revenue This Year | N/A | $8.52 |
| Revenue Next Year | N/A | $3.95 |
| P/E Ratio | ★ N/A | $20.73 |
| Revenue Growth | N/A | ★ 32.41 |
| 52 Week Low | $0.12 | $9.46 |
| 52 Week High | $6.52 | $14.00 |
| Indicator | BCAB | STRW |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 57.49 |
| Support Level | $0.36 | $12.51 |
| Resistance Level | $6.33 | $13.46 |
| Average True Range (ATR) | 0.53 | 0.46 |
| MACD | -0.25 | 0.01 |
| Stochastic Oscillator | 12.27 | 78.07 |
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs. The company's operations are organized on a single reportable segment, which includes all activities related to the discovery, development, and commercialization of its CAB products.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.